Pfizer standalone net profit declines 14.83% in the September 2020 quarter
Sales rise 5.00% to Rs 595.41 crore
Net profit of Pfizer declined 14.83% to Rs 131.37 crore in the quarter ended September 2020 as against Rs 154.25 crore during the previous quarter ended September 2019. Sales rose 5.00% to Rs 595.41 crore in the quarter ended September 2020 as against Rs 567.06 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales595.41567.06 5 OPM %34.1528.95 -PBDT210.76206.31 2 PBT183.03181.18 1 NP131.37154.25 -15Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content